Equity Issuances

Stellus Private Credit BDC issued 160,193 common shares of common stock for an aggregate offering price of $2,449,352.41.

“On September 30, 2025, Stellus Private Credit BDC (the “Company”) issued 160,193 common shares of beneficial interest (the “Shares”) of the Company for an aggregate offering price of $2,449,352.41.”

Fly-E Group, Inc. issued an aggregate of 13,750,000 shares of common stock of common stock to certain non-U.S. investors for gross proceeds of $11 million, before the deduction of customary expenses.

“sale of the Shares occurred on September 30, 2025 when all the closing conditions of the SPA have been satisfied. The Company issued the Shares in exchange for gross proceeds of $11 million, before the deduction of customary expenses. The Shares were issued in reliance on the exemption from registration provided by Regulation S under the Securities Act of 1933.”

Andalusian Credit Company, LLC issued 1,991,586 shares of common stock to accredited investors for aggregate net offering price of $30,592,082.

“On September 29, 2025, pursuant to a capital drawdown notice previously delivered to its investors, Andalusian Credit Company, LLC (the “Company”) issued and sold 1,991,586 shares of the Company’s limited liability company interests, par value $0.001 per share (the “Shares”), for an aggregate net offering price of $30,592,082.”

Stonepeak-Plus Infrastructure Fund LP issued 156,604 Units of unit to third-party investors, including through Stonepeak-Plus Infrastructure Fund (TE) LP for $4,550,000.

“On September 1, 2025, Stonepeak-Plus Infrastructure Fund LP (the “ Fund”) sold unregistered limited partnership units (the “ Units”) for aggregate consideration of approximately $31,977,500. (1) The following table provides details on the Units sold by the Fund (rounding to the nearest whole number): Number of Units Sold (2) Aggregate Consideration Class A-1a 956,752 $ 27,427,500 Class I-1 156,604 $ 4,550,000”

Stonepeak-Plus Infrastructure Fund LP issued 956,752 Units of unit to third-party investors, including through Stonepeak-Plus Infrastructure Fund (TE) LP for $27,427,500.

“On September 1, 2025, Stonepeak-Plus Infrastructure Fund LP (the “ Fund”) sold unregistered limited partnership units (the “ Units”) for aggregate consideration of approximately $31,977,500. (1) The following table provides details on the Units sold by the Fund (rounding to the nearest whole number): Number of Units Sold (2) Aggregate Consideration Class A-1a 956,752 $ 27,427,500 Class I-1 156,604 $ 4,550,000”

BlackRock Monticello Debt Real Estate Investment Trust issued 123,185.0391 common shares of common stock to third party investors and one or more officers, trustees, directors or employees of the Company’s investment advisers or their affiliates for $3,080,000.

“In connection with the continuous private offering of BlackRock Monticello Debt Real Estate Investment Trust (the “Company”), on October 1, 2025, the Company sold an aggregate of 123,185.0391 common shares (the “Shares”) for aggregate consideration of $3,080,000 to third party investors and one or more officers, trustees, directors or employees of the Company’s investment advisers or their affiliates.”

BNB PLUS CORP. issued warrants to purchase Common Stock (the “Advisory Warrants”) equal to 9.5% of the shares of Common Stock outstanding on the date of the closing of the Offering of warrant to Cypress Management LLC.

“issue to the Strategic Advisor five (5) year warrants to purchase Common Stock (the “Advisory Warrants”) equal to 9.5% of the shares of Common Stock outstanding on the date of the closing of the Offering”

BNB PLUS CORP. issued 3,444,164 Series E-2 Warrants (the “Cryptocurrency Common Warrants”) at a per share exercise price of $3.82 of warrant to accredited investors.

“3,444,164 Series E-2 Warrants (the “Cryptocurrency Common Warrants”) at a per share exercise price of $3.82”

BNB PLUS CORP. issued 3,444,164 prefunded warrants (the “Cryptocurrency Prefunded Warrants”) of warrant to accredited investors for offering price of $3.32 per share.

“3,444,164 prefunded warrants (the “Cryptocurrency Prefunded Warrants”), at an offering price of $3.32 per share, to purchase shares of Common Stock at a per share exercise price of $3.82”

BNB PLUS CORP. issued Series E-1 Warrants (the “Common Warrants”) to purchase 4,620,485 shares of Common Stock at a per share exercise price of $3.82 of warrant to accredited investors.

“Series E-1 Warrants (the “Common Warrants”) to purchase 4,620,485 shares of Common Stock at a per share exercise price of $3.82”

BNB PLUS CORP. issued 4,620,485 shares of common stock to accredited investors for $3.32 per share.

““Cash Purchasers”) pursuant to which the Company agreed to sell and issue to the Cash Purchasers in a private placement offering (the “Cash Offering”), at an offering price of $3.32 per share, an aggregate of 4,620,485 shares (the “Shares”) of common stock of the Company, par value $0.001 per share (the “Common Stock”), and/or prefunded warrants in lieu”

Clean Energy Technologies, Inc. issued common stock.

“Clean Energy Technology, Inc. (the “ Company ”), filed a Certificate of Change with the State of Nevada to effect a 1-for-15 reverse stock split of the Company’s (a) authorized shares of common stock, and (b) issued and outstanding shares of common stock (the “ Reverse Stock Split ”), which was accepted for filing by the State of Nevada on or about September 26, 2025.”

Axe Compute Inc. issued pre-funded warrants to purchase an aggregate of up to approximately 223.6 million shares of Common Stock of warrant to certain accredited investors for combination of digital assets, including primarily Aethir tokens (ATH).

“On September 29, 2025, the Company, in a separate private placement transaction, entered into a securities purchase agreement (the “ Cryptocurrency Securities Purchase Agreement ” and, together with the Cash Securities Purchase Agreement, the “ Securities Purchase Agreements ”) with certain accredited investors (the “ Cryptocurrency Purchasers ” and, together with the Cash Purchasers, the “ Purchasers ”) pursuant to which the Company agreed to sell and issue to the Cryptocurrency Purchasers in a private placement (the “ Cryptocurrency Offering ” and, together with the Cash Offering, the “ Private Placements ”) pre-funded warrants (the “ Cryptocurrency Pre-Funded Warrants ” and, together with the Cash Pre-Funded Warrants, the “ Pre-Funded Warrants ” and, together with the Cash Securities, the “ Securities ”) to purchase an aggregate of up to approximately 223.6 million shares of Common Stock (the “ Cryptocurrency Pre-Funded Warrant Shares ” and, together with the Cash Pre-Funded Warrant”

Axe Compute Inc. issued pre-funded warrants to purchase an aggregate of up to approximately 11.5 million shares of Common Stock of warrant to certain accredited investors for purchase price per Cash Pre-Funded Warrant equal to the Cash Per Share Purchase Price minus the Cash Pre-Funded Warrant Exercise Price, pre-funded on the Closin.

“On September 29, 2025, Predictive Oncology Inc., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (the “ Cash Securities Purchase Agreement ”) with certain accredited investors (the “ Cash Purchasers ”) pursuant to which the Company agreed to sell and issue to the Cash Purchasers in a private placement (the “ Cash Offering ”) an aggregate of (i) approximately 55.2 million shares (the “ Shares ”) of common stock of the Company, par value $0.01 per share (the “ Common Stock ”), at a purchase price of $0.7751 per share (the “ Cash Per Share Purchase Price ”), and/or (ii) pre-funded warrants to purchase an aggregate of up to approximately 11.5 million shares of Common Stock (the “ Cash Pre-Funded Warrants ” and together with the Shares, the “ Cash Securities ”) to purchase shares of Common Stock (the “ Cash Pre-Funded Warrant Shares ”) at a purchase price per Cash Pre-Funded Warrant equal to the Cash Per Share Purchase Price minus the Cash Pre-Funded W”

Axe Compute Inc. issued approximately 55.2 million shares of common stock to certain accredited investors for U.S. dollars at a purchase price of $0.7751 per share.

“On September 29, 2025, Predictive Oncology Inc., a Delaware corporation (the “ Company ”), entered into a securities purchase agreement (the “ Cash Securities Purchase Agreement ”) with certain accredited investors (the “ Cash Purchasers ”) pursuant to which the Company agreed to sell and issue to the Cash Purchasers in a private placement (the “ Cash Offering ”) an aggregate of (i) approximately 55.2 million shares (the “ Shares ”) of common stock of the Company, par value $0.01 per share (the “ Common Stock ”), at a purchase price of $0.7751 per share (the “ Cash Per Share Purchase Price ”), and/or (ii) pre-funded warrants to purchase an aggregate of up to approximately 11.5 million shares of Common Stock (the “ Cash Pre-Funded Warrants ” and together with the Shares, the “ Cash Securities ”) to purchase shares of Common Stock (the “ Cash Pre-Funded Warrant Shares ”) at a purchase price per Cash Pre-Funded Warrant equal to the Cash Per Share Purchase Price minus the Cash Pre-Funded W”

Volato Group, Inc. issued 1,197,604 shares of the Company’s Class A common stock of common stock to Tysadco Partners, LLC, and Douglas Cole for exchange for an aggregate of 16,000,000 shares of M2i Global common stock, valued at an aggregate of $2,000,000.

“Pursuant to the Agreements, the Company agreed to issue an aggregate of 1,197,604 shares of the Company’s Class A common stock (the “Volato Shares”) to the Investors in exchange for an aggregate of 16,000,000 shares of M2i Global common stock (the “M2i Shares”).”

Kodiak AI, Inc. issued common stock.

“The Certificate of Incorporation and Bylaws contain material modifications, among others, to the Company’s authorized capital stock, exclusive forum, shareholder voting rights, removal of directors, voting requirements to amend the Certificate of Incorporation and Bylaws.”

Kodiak AI, Inc. issued Non-Redemption Shares of common stock.

“The Assumed Kodiak Warrants, PIPE Warrants, the Preferred Stock, the PIPE Shares, the Legacy Kodiak Advisor Shares, the Non-Redemption Shares and Non-Redemption Warrants have not been registered under the Securities Act, in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.”

Kodiak AI, Inc. issued preferred stock.

“The Assumed Kodiak Warrants, PIPE Warrants, the Preferred Stock, the PIPE Shares, the Legacy Kodiak Advisor Shares, the Non-Redemption Shares and Non-Redemption Warrants have not been registered under the Securities Act, in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.”

Kodiak AI, Inc. issued warrant.

“The Assumed Kodiak Warrants, PIPE Warrants, the Preferred Stock, the PIPE Shares, the Legacy Kodiak Advisor Shares, the Non-Redemption Shares and Non-Redemption Warrants have not been registered under the Securities Act, in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.”

Kodiak AI, Inc. issued PIPE Shares of common stock.

“The Assumed Kodiak Warrants, PIPE Warrants, the Preferred Stock, the PIPE Shares, the Legacy Kodiak Advisor Shares, the Non-Redemption Shares and Non-Redemption Warrants have not been registered under the Securities Act, in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder.”

MAIA Biotechnology, Inc. issued 19,230 of warrant to Stan Smith for Issued in conjunction with Director Shares; exercisable at $1.57 per share.

“Investor Shares and 769,230 Investor Warrants for an aggregate purchase price of approximately $1 million. The Investor Warrants are exercisable at a price per Investor Share of $1.57, which price represents the “Minimum Price” as defined under NYSE American Rule 713 on the date the Purchase Agreement was executed (subject to customary adjustments as set”

MAIA Biotechnology, Inc. issued 19,230 of common stock to Stan Smith for $1.30 per share, aggregate approximately $25,000.

“Company director Stan Smith subscribed to purchase 19,230 Director Shares and 19,230 Director Warrants for an aggregate purchase price of approximately $25,000.”

MAIA Biotechnology, Inc. issued 769,230 of warrant to FGMK Business Holdings, LLC for Issued in conjunction with Investor Shares; exercisable at $1.57 per share.

“Investor Shares and 769,230 Investor Warrants for an aggregate purchase price of approximately $1 million. The Investor Warrants are exercisable at a price per Investor Share of $1.57, which price represents the “Minimum Price” as defined under NYSE American Rule 713 on the date the Purchase Agreement was executed (subject to customary adjustments as set”

MAIA Biotechnology, Inc. issued 769,230 of common stock to FGMK Business Holdings, LLC for $1.30 per share, aggregate approximately $1,000,000.

“FGMK Business Holdings, LLC, a greater than 5% holder, subscribed to purchase 769,230 Investor Shares and 769,230 Investor Warrants for an aggregate purchase price of approximately $1 million.”

MAIA Biotechnology, Inc. issued 1,714,536 of warrant to Investors for Issued in conjunction with Investor Shares; exercisable at $1.57 per share.

“The Investor Warrants are exercisable at a price per Investor Share of $1.57, which price represents the "Minimum Price" as defined under NYSE American Rule 713 on the date the Purchase Agreement was executed (subject to customary adjustments as set forth in the Investor Warrants, which do not include any provisions relating to price protection), are exercisable commencing six-months following issuance and have a term of three years from the issuance date.”

MAIA Biotechnology, Inc. issued 1,714,536 of common stock to Investors for $1.30 per share, aggregate $2,228,896.

“MAIA Biotechnology, Inc. (the " Company ") entered into a Securities Purchase Agreement (the " Purchase Agreement ") with certain accredited investors (the " Investors ") for the issuance and sale in a private placement (the " Private Placement ") of: (i) 1,714,536_shares (the " Investor Shares ") of the Company's common stock, par value $0.0001 per share (" Common Stock "), and (ii) warrants (the " Investor Warrants ") to purchase up to 1,714,536 shares of Common Stock, at a purchase price per Investor Share of $1.30, for an aggregate purchase price of approximately $2,228,896.”

KOPIN CORP issued 19,545,950 shares of common stock to accredited investors for approximately $38.1 million net proceeds.

““PIPE”) for 19,545,950 shares of its common stock, par value $0.01 per share (the “Shares”). The net proceeds to the Company from the offering are estimated to be approximately $38.1 million, after deducting placement agent fees and commissions and estimated offering expenses payable by the Company. The transaction is expected to close on September 30, 2025, subject”

GeoVax Labs, Inc. issued 11,904,768 shares of Common Stock of warrant.

“In a concurrent private placement, the Company offered common warrants to the purchasers, with each warrant exercisable to purchase one share of Common Stock (the “Common Warrants”), with three Common Warrant to accompany each share of Common Stock sold in the Offering, and to purchase in the aggregate of 11,904,768 shares of Common Stock (the “Common Warrant Shares”).”

GeoVax Labs, Inc. issued 3,968,256 shares of common stock for $0.63 per Share.

“share of Common Stock sold in the Offering, and to purchase in the aggregate of 11,904,768 shares of Common Stock (the “Common Warrant Shares”). The public offering price was $0.63 for each Share coupled with the Common Warrants. The Common Warrants have an exercise price of $0.63 per share. Under the terms of the Purchase Agreement and to comply with Nasdaq”

WOLFSPEED, INC. issued approximately 1,306,896 shares of New Common Stock of common stock to existing equity holders for pro rata share for cancellation of Old Common Stock.

“all of the previously issued and outstanding shares of Old Common Stock were cancelled, and existing equity holders received their pro rata share of approximately 1,306,896 shares of New Common Stock.”

WOLFSPEED, INC. issued 4,943,555 shares of warrant to Renesas Electronics America Inc. for exercise price of $23.95 per share.

“Wolfspeed issued a warrant (the “Renesas Warrant”) to Renesas Electronics America Inc. (“Renesas”) to purchase an aggregate of 4,943,555 shares of Wolfspeed’s common stock, par value $0.00125 per share (the “New Common Stock”), at an exercise price of $23.95 per share.”

BXP, Inc. issued 13,252,000 shares of common stock of convertible note to initial purchasers for $1.0 billion aggregate principal amount of 2.00% Exchangeable Senior Notes due 2030.

“The Notes were issued to the initial purchasers in reliance upon Section 4(a)(2) of the Securities Act in transactions not involving any public offering.”

COMSCORE, INC. issued 3,286,825 shares of Common Stock of warrant to Charter Communications Holding Company, LLC, Liberty Broadband Corporation, and Pine Investor, LLC for Exchange of 31,928,301 shares of Series B Convertible Preferred Stock for Series C Preferred Stock and Common Stock.

“On September 26, 2025, comScore, Inc. (the “ Company ”) entered into separate Stock Exchange Agreements (individually, an “ Exchange Agreement ” and collectively, the “ Exchange Agreements ”) with each of Charter Communications Holding Company, LLC, a Delaware limited liability company (“ Charter ”), Liberty Broadband Corporation, a Delaware corporation (“ Liberty ”), and Pine Investor, LLC, a Delaware limited liability company wholly owned by funds advised by Cerberus Capital Management, L.P. (“ Pine ” and together with Charter and Liberty, referred to herein collectively as the “ Stockholders ” and individually as a “ Stockholder ”), pursuant to which, among other things, at the closing of the transactions contemplated thereby (the “ Closing ”), and on the terms and subject to the conditions set forth therein, each Stockholder will exchange the 31,928,301 shares of Series B Convertible Preferred Stock, par value $0.001 per share, of the Company (“ Series B Preferred Stock ”) currentl”

COMSCORE, INC. issued 4,223,621 shares of Series C Convertible Preferred Stock of preferred stock to Charter Communications Holding Company, LLC, Liberty Broadband Corporation, and Pine Investor, LLC for Exchange of 31,928,301 shares of Series B Convertible Preferred Stock for Series C Preferred Stock and Common Stock.

“On September 26, 2025, comScore, Inc. (the “ Company ”) entered into separate Stock Exchange Agreements (individually, an “ Exchange Agreement ” and collectively, the “ Exchange Agreements ”) with each of Charter Communications Holding Company, LLC, a Delaware limited liability company (“ Charter ”), Liberty Broadband Corporation, a Delaware corporation (“ Liberty ”), and Pine Investor, LLC, a Delaware limited liability company wholly owned by funds advised by Cerberus Capital Management, L.P. (“ Pine ” and together with Charter and Liberty, referred to herein collectively as the “ Stockholders ” and individually as a “ Stockholder ”), pursuant to which, among other things, at the closing of the transactions contemplated thereby (the “ Closing ”), and on the terms and subject to the conditions set forth therein, each Stockholder will exchange the 31,928,301 shares of Series B Convertible Preferred Stock, par value $0.001 per share, of the Company (“ Series B Preferred Stock ”) currentl”

Lexaria Bioscience Corp. issued 93,333 common stock warrants to purchase up to 93,333 shares of Common Stock of warrant to H.C. Wainwright & Co., LLC for exercise price of $1.875 per share of Common Stock.

“number of Shares issued and sold on the Closing Date. The Placement Agent Warrants expire five years from the commencement of sales of the Offering and have an exercise price of $1.875 per share of Common Stock. armel, LLP, securities counsel to the Company, delivered an opinion as to the validity of the Shares, a copy of which is filed as Exhibit 5.1 to this”

Lexaria Bioscience Corp. issued 2,666,667 common stock purchase warrants of warrant to certain institutional investors for exercise price of $1.37 per share of Common Stock.

“and (ii) in a concurrent private placement, 2,666,667 common stock purchase warrants (the “Private Placement Warrants”), exercisable for an aggregate of up to 2,666,667 shares of Common Stock, at an exercise price of $1.37 per share of Common Stock.”

Bunker Hill Mining Corp. issued 520,052 Compensation Options of option to ZED Financial Partners and its principals for issued as compensation, exercisable at C$0.12 per share.

“”), closed the previously announced “bought deal” private placement of units of the Company (the “ Units ”). The Company issued (i) 206,250,000 Units at a price per Unit of C$0.12 (the “ CAD Offer Price ”) for gross proceeds of C$24,750,000 (the “ CAD Offering ”) (which includes the full exercise of the underwriters’ over-allotment option) and (ii)”

Bunker Hill Mining Corp. issued 25,325,428 Compensation Options of option to Haywood Securities Inc. and BMO Nesbitt Burns Inc. for issued as compensation, exercisable at C$0.12 per share.

“”), closed the previously announced “bought deal” private placement of units of the Company (the “ Units ”). The Company issued (i) 206,250,000 Units at a price per Unit of C$0.12 (the “ CAD Offer Price ”) for gross proceeds of C$24,750,000 (the “ CAD Offering ”) (which includes the full exercise of the underwriters’ over-allotment option) and (ii)”

Bunker Hill Mining Corp. issued 225,000,000 Units of unit to Teck Resources Limited and other accredited investors for US$0.08711 per Unit.

“and (ii) 225,000,000 Units at a price per Unit of US$0.08711 (the “ USD Offer Price ”) for gross proceeds of US$19,599,750 (the “ USD Offering ”, and together with the CAD Offering, collectively, the “ Offering ”)”

Bunker Hill Mining Corp. issued 206,250,000 Units of unit to director, executive officer, and other accredited investors for C$0.12 per Unit.

“The Company issued (i) 206,250,000 Units at a price per Unit of C$0.12 (the “ CAD Offer Price ”) for gross proceeds of C$24,750,000 (the “ CAD Offering ”) (which includes the full exercise of the underwriters’ over-allotment option)”

INVO Fertility, Inc. issued 467 additional shares of Series C-2 Preferred Stock of preferred stock to Five Narrow Lane LP for aggregated stated value of 1,334,000.

“the Company and Five Narrow Lane LP, a Delaware limited partnership (“ FNL ”) entered into an agreement (the “ Exchange Agreement ”) pursuant to which FNL agreed to exchange a Second Amended and Restated Senior Secured Convertible Debenture Due February 11, 2026 (the “ Second Amended and Restated Debenture ”) held by FNL for receipt of shares of Series C-2 Convertible Preferred Stock (the “ Series C-2 Preferred Stock ”) with an aggregated stated value of 1,334,000. In consideration thereof, the Company agreed to issue 467 additional shares of Series C-2 Preferred Stock to FNL.”

AMERICAN REBEL HOLDINGS INC issued 2,000 shares of newly authorized Series E Preferred Stock of preferred stock to Streeterville Capital, LLC for acquiring a $2,000,000 interest in a secured promissory note issued by Damon, Inc..

“On August 22, 2025, American Rebel Holdings, Inc. executed a Note Purchase Agreement (NPA) with Streeterville Capital, LLC, acquiring a $2,000,000 interest in a secured promissory note issued by Damon, Inc., a publicly traded Canadian company. In exchange, American Rebel issued 2,000 shares of newly authorized Series E Preferred Stock.”

AMERICAN REBEL HOLDINGS INC issued a three-year pre-funded warrant to purchase 699,680 shares of the Company’s common stock at $0.01 per share of warrant to Agile Capital Funding, LLC for valued at $1.24 per share.

“Note : On August 15, 2025 the Company announced previously via 8K announcing a Settlement and Exchange Agreement with Agile Capital Funding, LLC that removed the junior lien on Champion Safe Co. Pursuant to the Securities Exchange Agreement, AREB and Agile exchanged all amounts due pursuant to the Loan Agreement for 414,500 shares of the Company’s common stock, valued at $1.25 per share , and a three-year pre-funded warrant to purchase 699,680 shares of the Company’s common stock at $0.01 per share, valued at $1.24 per share.”

AMERICAN REBEL HOLDINGS INC issued 175,000 shares of common stock of common stock to Corey Lambrecht for upon the conversion of 350 shares of Series A Convertible Preferred Stock.

“On September 25, 2025, the Company authorized the issuance of 175,000 shares of common stock to Corey Lambrecht, the Company’s President, COO and a director, upon the conversion of 350 shares of Series A Convertible Preferred Stock.”

AMERICAN REBEL HOLDINGS INC issued 175,000 shares of common stock of common stock to Charles A. Ross, Jr. for upon the conversion of 350 shares of Series A Convertible Preferred Stock.

“On September 25, 2025, the Company authorized the issuance of 175,000 shares of common stock to Charles A. Ross, Jr., the Company’s Chairman and CEO, upon the conversion of 350 shares of Series A Convertible Preferred Stock.”

Edgemode, Inc. issued 4,250,000 shares of common stock to Crom Structured Opportunities Fund I, LP.

“the Company sold Crom an unsecured original issue discount promissory note in the principal amount of $143,750 (the “Crom Promissory Note”) for which the Company received net proceeds of $125,000”

Edgemode, Inc. issued 3,400,000 shares of common stock to LGH Investments, LLC.

“the Company sold LGH an unsecured original issue discount promissory note in the principal amount of $115,000 (the “LGH Promissory Note”) for which the Company received net proceeds of $100,000”

HERTZ GLOBAL HOLDINGS, INC issued 60,975,600 shares of Common Stock of common stock to holders of the Notes.

“Initially, a maximum of 60,975,600 shares of Common Stock may be issued upon exchange of the Notes”

HERTZ GLOBAL HOLDINGS, INC issued convertible note to initial purchasers for $425,000,000 aggregate principal amount.

“(“Hertz Corp.”), the primary operating company and wholly-owned indirect subsidiary of Hertz Global Holdings, Inc. (the “Company” or “Hertz Holdings”), completed an offering of $425,000,000 aggregate principal amount of its 5.500% Exchangeable Senior Notes due 2030 (the “Notes”), which includes the exercise in full of the initial purchasers’ option to purchase up to”